Sherine M. Abdelmawla, Ph.D. (Co-founder and CEO): Sherine has over 11 years of experience working in academia, and the biotechnology and pharmaceutical industries; within R&D and clinical divisions; to develop HCV inhibitors, nucleic acid based cancer therapeutics, and cancer diagnostics. Sherine serves on few boards including MatchBox Co-working Board of Directors and Ivy Tech Community College, Chemical Technology Advisory Board. Sherine holds a Ph.D. in Medicinal Chemistry and Molecular Pharmacology from Purdue University and a B.S. degree with honors in Pharmaceutical Sciences from Cairo University, School of Pharmacy where she held a faculty position until 2014.
Mohammad N. Noshi, Ph.D. (Co-founder, President of R&D and COO): Noshi has over 10 years of experience within the academic and industrial settings developing chemistry methodologies, synthesis of anti-cancer natural products, complex alkaloids synthesis, diagnostic agents for image guided surgery in cancer, and potential drug candidates for Alzheimer 's disease and prostate cancer. Noshi holds Ph.D. in Organic Chemistry from Purdue University, postdoctoral experience from MIT, M.S. in Medicinal Chemistry from The University of Toledo, and a B.S. with honors in Pharmaceutical Sciences from Cairo University where he held a faculty position.
Philip L. Fuchs, Ph.D. (Co-founder and CSO): Fuchs has been on the Purdue Faculty since 1973. He is currently the Emeritus R. B. Wetherill Professor of Chemistry and holds Purdue's highest scientific award, the McCoy Research award. He published more than 240 papers and granted 71 PhD's dedicated to total organic synthesis of natural products and methodologies. Fuchs has consulted for Pfizer and Eli Lilly, has served on the editorial board of the Journal of Organic Chemistry, and is the Editor-in-Chief for EROS. Fuchs holds a Ph.D. from the University of Wisconsin, and moved to Harvard for a postdoctoral fellowship with the Nobel Prize winner, E. J. Corey.
3495 Kent Avenue, Suite E-100
Copyright © 2016 Akanocure Pharmaceuticals, Inc.